Interventional Cardiovascular Devices Market Size, Share, Tr...| MENAFN.COM

Friday, 01 July 2022 02:03 GMT

Interventional Cardiovascular Devices Market Size, Share, Trends, And Report From 2022 To 2031


(MENAFN- America News Hour)

Kenneth Research recently added a report on 'Interventional Cardiovascular Devices Market' in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Interventional Cardiovascular Devices Market, along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter's five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Interventional Cardiovascular Devices Market products.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: 

According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

Over the recent years, global interventional cardiovascular devices market has been witnessing growth, on account of several driving factors including increase in geriatric population, increasing awareness for minimally invasive cardiac procedures and prevailing unhealthy lifestyle habits. Moreover, rising medical infrastructure developments with increase in medical facilities is expected to propel the demand for interventional cardiovascular devices market.

In this research report, the market is segmented on the basis of product type. By Product Type, the segment of stent is predicted to hold its dominant position in the market in the historic as well as forecast period. Amongst the regions, North America accounts for the largest regional share, by value in the global interventional cardiovascular devices market in 2018. However, Asia Pacific is predicted to advance at the highest rate. Presence of vast consumer base, particularly in emerging nations such as China and India, in addition to growing per capita expenditure on healthcare is likely to drive the regional market.

The report titled“Global Interventional Cardiovascular Devices Market: Analysis By Product Type (Catheter, Stent, Balloon, Guidewire, Systems), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) – By Region (North America, Europe, Asia-Pacific, Rest of the World), By Country (U.S, Canada, Germany, U.K, Japan, China, India, Brazil)” has covered and analyzed the potential of global interventional cardiovascular devices market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global interventional cardiovascular devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Interventional Cardiovascular Devices Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
• Global Interventional Cardiovascular Devices Market – Size, Growth and Forecast
• By Product Type (Catheter, Balloon, Stent, Guidewire, Systems)
• Market Share Analysis
• Market Attractiveness By Product Type

Regional Markets – North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)
• Regional Interventional Cardiovascular Devices Market – Size, Growth and Forecast
• By Product Type (Catheter, Balloon, Stent, Guidewire, Systems)
• Major Market Players

Country Analysis – US, Canada, UK, Germany, China, Japan, India, Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)
• Interventional Cardiovascular Devices Market– Size, Growth and Forecast
• By Product Type (Catheter, Balloon, Stent, Guidewire, Systems)

Other Report Highlights
• Competitive Landscape (Company share analysis, Product Benchmarking, Brand Analysis, New Product Approvals)
• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Company Analysis – Abbott Laboratories, Acrostak, B. Braun Melsungen, Biosensors International, Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic, Terumo Corporation.

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

MENAFN23062022004545010068ID1104420019


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.